tiprankstipranks
Trending News
More News >
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market

3D Medicines, Inc. (1244) Income Statement

Compare
2 Followers

3D Medicines, Inc. Income Statement

Last quarter (Q2 2025), 3D Medicines, Inc.'s total revenue was ¥209.17M, a decrease of -40.67% from the same quarter last year. In Q2, 3D Medicines, Inc.'s net income was ¥-89.35M. See 3D Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 445.65M¥ 634.95M¥ 567.39M¥ 60.26M¥ 0.00
Gross Profit
¥ 371.74M¥ 524.01M¥ 525.18M¥ 55.98M¥ 0.00
Operating Expenses
¥ 495.17M¥ 1.02B¥ 846.54M¥ 559.07M¥ 303.93M
Depreciation and Amortization
¥ 7.86M¥ 25.46M¥ 21.60M¥ 12.59M¥ 1.15M
EBITDA
¥ -226.95M¥ -529.23M¥ -1.03B¥ -1.45B¥ -303.35M
Operating Income
¥ -123.43M¥ -497.25M¥ -386.17M¥ -516.25M¥ -304.50M
Other Income/Expenses
¥ -75.95M¥ -65.22M¥ -665.86M¥ -945.57M¥ -330.88M
Pretax Income
¥ -199.38M¥ -562.47M¥ -1.05B¥ -1.46B¥ -635.38M
Net Income
¥ -182.66M¥ -524.70M¥ -1.02B¥ -1.43B¥ -635.38M
Per Share Metrics
Basic EPS
¥ -0.75¥ -2.30¥ -22.52¥ -36.72¥ -13.93
Diluted EPS
¥ -0.75¥ -2.30¥ -22.52¥ -36.72¥ -13.93
Weighted Average Shares Outstanding
244.96M 228.47M 45.49M 39.05M 45.60M
Weighted Average Shares Outstanding (Diluted)
244.96M 228.47M 45.49M 39.05M 45.60M
Currency in CNY

3D Medicines, Inc. Earnings and Revenue History